Halozyme Therapeutic (HALO)
$16.09 0.39 (2.37%)
12:32 EDT HALO Stock Quote Delayed 15 Minutes
Previous Close $16.48
Market Cap 2.32B
PE Ratio 30.94
Volume (Avg. Vol.) 126,108
Day's Range 16.02 - 16.53
52-Week Range 13.24 - 18.85
Dividend & Yield N/A (N/A)
HALO Stock Predictions, Articles, and Halozyme Therapeutic News
- From InvestorPlace
- From the Web
Why Foot Locker, Inc. (FL), Campbell Soup Company (CPB) and Halozyme Therapeutics, Inc. (HALO) Are 3 of Today’s Worst Stocks
Foot Locker (FL), Campbell Soup (CPB) and Halozyme Therapeutics (HALO) shareholders won't be starting the weekend in the best of moods.
These small-cap stocks all have the potential to dish out misery, but if things work out just right, look out above.
3 Stocks to Watch on Thursday: Kohl’s Corporation (KSS), Halozyme Therapeutics, Inc. (HALO) and Sears Holdings Corp (SHLD)
Kohl's (KSS) is battered by an awful holiday performance, Sears (SHLD) sells off Craftsman and Halozyne (HALO) reports strong trial data.
Partnerships with the likes of ABV, PFE and LLY are helping Halozyme (HALO) stock turn toward the upside.
he current market cap for Halozyme Therapeutics (HALO) is at $1.5 billion, which makes it ripe as a takeover target.
Healthcare stocks rose broadly on Wall Street on Monday, with the sector seeing an overall increase of 0.3%.
Healthcare stocks advanced 0.8% on Wall Street on Friday morning.
Healthcare stocks declined broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 1.7%.
Healthcare stocks declined 1.9% on Wall Street today.
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 1.8%.
Healthcare stocks declined 2.0% on Wall Street on Monday.
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.6%.
Healthcare stocks declined 0.5% on Wall Street on Wednesday morning.
Healthcare stocks declined on Wall Street on Tuesday morning, down 0.6%.
Healthcare stocks fell on Wall Street on Friday morning, down 0.6%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks finished flat on Monday on Wall Street.
From Simply Wall St
If you’re interested in Halozyme Therapeutics, Inc. (NASDAQ:HALO), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/does-the-halozyme-therapeutics-inc-nasdaqhalo-share-price-fall-with-the-market-2/">Read More...</a></div>
From Analyst Ratings
In a report issued on August 7, Gena Wang from Barclays maintained a Sell rating on Halozyme (HALO – Research Report), with a price target of $17. The company’s shares closed on Friday at $16.03. According to TipRanks.com, Wang is a 5-star analyst with an average return of 18.3% and a 50.6% success rate. Wang
From The Motley Fool
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!